Goldman Sachs’s Lifestance Health LFST Stock Holding History

Goldman Sachs’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-566,600	Closed	-$3.12M	–	6669
2025 Q3	$3.12M	Hold	566,600	–	–	﹤0.01%	4074
2025 Q2	$2.93M	Hold	566,600	–	–	﹤0.01%	3882
2025 Q1	$3.77M	Hold	566,600	–	–	﹤0.01%	3621
2024 Q4	$4.18M	Hold	566,600	–	–	﹤0.01%	3631
2024 Q3	$3.97M	Hold	566,600	–	–	﹤0.01%	3558
2024 Q2	$2.78M	Buy	566,600 +459,300	+428%	+$2.77M	﹤0.01%	3674
2024 Q1	$662K	Sell	107,300 -4,000	-4%	-$26.9K	﹤0.01%	4594
2023 Q4	$871K	Sell	111,300 -87,500	-44%	-$564K	﹤0.01%	4454
2023 Q3	$1.37M	Buy	198,800 +41,300	+26%	+$335K	﹤0.01%	4050
2023 Q2	$1.44M	Buy	157,500 +70,000	+80%	+$582K	﹤0.01%	4104
2023 Q1	$650K	Buy	+87,500	New	+$485K	﹤0.01%	4678

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SPIG

Silversmith Partners I GP Boston, Massachusetts $39.2M AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs's LFST Position: Q1 2026 in Review

Goldman Sachs reduced its Lifestance Health (LFST) stake by 37% in Q1 2026, selling an estimated $8.36M and leaving 2,086,443 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2817.

Goldman Sachs first reported a position in LFST in Q2 2021 and has held it in 20 quarters since. The position peaked at $30.1M in Q4 2024. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

Goldman Sachs held 2,086,443 shares of Lifestance Health worth $13.3M as of Q1 2026.
Goldman Sachs sold 1,201,194 Lifestance Health shares in Q1 2026, an estimated $8.36M.
Lifestance Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2817 holding.
Goldman Sachs first reported a position in Lifestance Health in Q2 2021 and has held it in 20 quarters since.
Goldman Sachs's Lifestance Health position peaked at $30.1M in Q4 2024.
228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.